Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 13.96% institutional investors, 41.61% insiders, and 44.43% retail investors. Vanguard group is the largest institutional shareholder, holding 3.72% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.66% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma13.96%41.61%44.43%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group845.50K3.72%$6.38M
Blackrock funding, inc. /de764.44K3.50%$5.91M
Iridian asset management llc/ct651.76K2.99%$5.04M
Geode capital management384.11K1.76%$2.97M
Baldwin brothers llc/ma378.63K1.74%$2.93M
State street166.52K0.76%$1.29M
Northern trust124.21K0.57%$960.16K
Vanguard fiduciary trust114.84K0.53%$887.73K
Blackrock83.41K0.50%$528.00K
Susquehanna group, llp105.29K0.48%$813.86K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Iridian asset management llc/ct651.76K2.04%$5.04M
Baldwin brothers llc/ma378.63K0.21%$2.93M
Forbes j m & co llp59.00K0.04%$456.07K
Austin wealth management20.13K0.04%$153.96K
Avalon trust14.00K0.01%$108.22K
Oppenheimer73.57K0.01%$568.66K
Eversource wealth advisors3.00K0.01%$175.91K
Nations financial group inc, /ia/ /adv13.00K0.01%$100.49K
Martingale asset management l p18.02K0.00%$139.33K
Nbc securities3.00K0.00%$23.19K

Top Buyers

HolderShares% AssetsChange
Vanguard group845.50K0.00%146.79K
Vanguard fiduciary trust114.84K0.00%114.84K
Citadel advisors78.42K0.00%78.42K
Iridian asset management llc/ct651.76K2.04%65.44K
Ubs group38.56K-30.19K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
Renaissance---42.80K
Millennium management29.70K0.00%-38.80K
Omers administration---32.88K
Qube research---30.59K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust114.84K0.00%114.84K$887.73K
Citadel advisors78.42K0.00%78.42K$606.23K
Martingale asset management l p18.02K0.00%18.02K$139.33K
Cibc private wealth group14.57K0.00%14.57K$110.03K
Price t rowe associates inc /md/12.05K-12.05K$94.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nisa investment advisors-12.00
Srs capital advisors-38.00
Point72 (difc)-49.00
Bryn mawr trust-61.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202637-27.45%3,045,927-28.14%134.01%16-44.83%5-44.44%
Dec 31, 202538-30.91%3,940,7276.65%175.80%23-8.00%6-60.00%
Sep 30, 20255519.57%3,694,86214.85%177.63%25-24.24%15114.29%
Jun 30, 20254932.43%3,242,70858.40%1514.40%3650.00%7133.33%
Mar 31, 20253719.35%2,047,14054.99%1017.47%2414.29%3-62.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv439.69K1.66%-
iShares Russell 2000 ETF344.26K1.30%2.91K
Vanguard Institutional Extnd Mkt Idx Tr209.89K0.79%37.86K
Fidelity Small Cap Index150.35K0.54%568.00
iShares Russell 2000 Growth ETF125.44K0.47%324.00
Fidelity Extended Market Index93.64K0.35%4.55K
Russell 2000 Equity Index Fund B78.54K0.30%115.00
Vanguard Russell 2000 ETF76.34K0.29%-47.00
State St Russell Sm Cap® Idx SL Cl I47.10K0.18%-
State St Russell Sm Cap® Indx SL Cl I47.10K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 05, 2025BENTSUR RON Chairman & CEOBuy$28.60K
Nov 05, 2025Sanchez Juan-Buy$75.27K
Nov 05, 2025Kaplan Matthew L.-Buy$64.24K
Oct 23, 2025Mosseri Marlio Charles-Buy$284.21K
Oct 24, 2025Mosseri Marlio Charles-Buy$215.46K

Insider Transactions Trends


DateBuySell
2025 Q46-
2025 Q218-
2025 Q11-
2024 Q461
2024 Q3--

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 13.96%, followed by 41.61% insiders and 44.43% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 34.84%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Vanguard group (845.5K shares, 3.72%), Blackrock funding, inc. /de (764.44K shares, 3.50%), and Iridian asset management llc/ct (651.76K shares, 2.99%). Together, they hold 10.21% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Iridian asset management llc/ct is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 2.04% of its assets in 651.76K Nuvectis Pharma shares, valued at 5.04M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 1.66% of its total shares outstanding invested in 439.69K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools